LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Search

CareDx Inc

Cerrado

SectorSalud

16.92 2.36

Resumen

Variación precio

24h

Actual

Mínimo

16.92

Máximo

17.04

Métricas clave

By Trading Economics

Ingresos

-88M

-10M

Ventas

-1.9M

85M

P/B

Media del Sector

15.134

53.54

BPA

0.1

Margen de beneficio

-12.225

Empleados

644

EBITDA

-6.1M

-13M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+69.08% upside

Dividendos

By Dow Jones

Próximas Ganancias

30 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-68M

944M

Apertura anterior

14.56

Cierre anterior

16.92

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

31 may 2025, 10:30 UTC

Principales Noticias

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 may 2025, 06:30 UTC

Ganancias

5 Things We've Learned From Retail Earnings -- Barrons.com

31 may 2025, 04:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 23:51 UTC

Adquisiciones, fusiones, absorciones

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 may 2025, 21:30 UTC

Principales Noticias

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 may 2025, 21:15 UTC

Principales Noticias

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 may 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

30 may 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 may 2025, 20:24 UTC

Principales Noticias

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 may 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 19:44 UTC

Charlas de Mercado

Gold Breaks 4-Month Winning Streak -- Market Talk

30 may 2025, 19:38 UTC

Charlas de Mercado

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 may 2025, 19:29 UTC

Ganancias
Adquisiciones, fusiones, absorciones

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 may 2025, 19:14 UTC

Charlas de Mercado

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 may 2025, 19:05 UTC

Charlas de Mercado

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 may 2025, 18:51 UTC

Charlas de Mercado

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 may 2025, 18:37 UTC

Charlas de Mercado
Ganancias

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 may 2025, 18:04 UTC

Principales Noticias

S&P 500 Falls After More Trump-China Friction -- WSJ

30 may 2025, 17:47 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 may 2025, 17:47 UTC

Charlas de Mercado

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 may 2025, 17:40 UTC

Adquisiciones, fusiones, absorciones

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 may 2025, 17:38 UTC

Charlas de Mercado

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 may 2025, 17:31 UTC

Charlas de Mercado

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 may 2025, 17:14 UTC

Principales Noticias

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 may 2025, 16:31 UTC

Ganancias

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 may 2025, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

30 may 2025, 16:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Health Care Roundup: Market Talk

30 may 2025, 16:16 UTC

Principales Noticias

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 may 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

30 may 2025, 16:14 UTC

Principales Noticias

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Comparación entre iguales

Cambio de precio

CareDx Inc Esperado

Precio Objetivo

By TipRanks

69.08% repunte

Estimación a 12 meses

Media 28 USD  69.08%

Máximo 40 USD

Mínimo 19 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

3

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.